Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention

NCT03145675 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT03145675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03145675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 12, 2017
Completion date
July 14, 2022
Enrollment
378 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, percutaneous coronary intervention